Ampio Pharm Valuation
| AMPE Stock | USD 0.29 0.02 7.41% |
Ampio Pharm seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Ampio Pharm from analyzing the firm fundamentals such as Current Valuation of (3.33 M), shares owned by insiders of 1.56 %, and Return On Equity of -1.14 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ampio Pharm's price fluctuation is out of control at this time. Calculation of the real value of Ampio Pharm is based on 3 months time horizon. Increasing Ampio Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ampio pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Ampio Pharm. Since Ampio Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ampio Pink Sheet. However, Ampio Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.29 | Real 0.2 | Hype 0.27 | Naive 0.13 |
The real value of Ampio Pink Sheet, also known as its intrinsic value, is the underlying worth of Ampio Pharm Company, which is reflected in its stock price. It is based on Ampio Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ampio Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ampio Pharm helps investors to forecast how Ampio pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ampio Pharm more accurately as focusing exclusively on Ampio Pharm's fundamentals will not take into account other important factors: About Ampio Pharm Valuation
The pink sheet valuation mechanism determines Ampio Pharm's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ampio Pharm. We calculate exposure to Ampio Pharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ampio Pharm's related companies.Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.
8 Steps to conduct Ampio Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ampio Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ampio Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ampio Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ampio Pharm's revenue streams: Identify Ampio Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ampio Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ampio Pharm's growth potential: Evaluate Ampio Pharm's management, business model, and growth potential.
- Determine Ampio Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ampio Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Ampio Pink Sheet analysis
When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |